FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.81, $0.18 better than the analyst estimate of $0.63. Revenue for the quarter came in at $238 million versus the consensus estimate of $237.72 million.

